Patrick Driscoll founded MedMarket Diligence in October 2001. Mr. Driscoll has over 20 years experience analyzing and writing on medical technology markets, encompassing medical devices, biotech and biopharmaceuticals. He was co-founder of Medtech Insight and prior to that, a principal at Medical Data International, and in these organizations built syndicated reports businesses and directed the companies' custom consulting activities. Mr. Driscoll received a BS from the University of Dallas, and an MBA from the University of New Hampshire's Whittemore School of Business & Economics.

medmarket reads one posterous blog.

Latest posts from

Gene Therapy Hastens Healing Process in Chronic Leg Ulcers on Dec 03
Continuous-flow vs. pulsatile LVAD on Dec 02
Neural control of prosthetics on Dec 02
Drug variations in drug-eluting stents on Dec 02
Adult Stem Cells Treating Heart Attack Patients on Dec 01

This blog has 3 subscribers:


Posts that medmarket has favorited recently...

Camp Photos

See medmarket's favorites »

Patrick's other stuff...

medmarket's twitter  medmarket's twitter
Patrick Driscoll's facebook profile  Patrick Driscoll's facebook profile
advanced medical technologies - insights, perspectives and inside data from the founder of MMD  advanced medical technologies - insights, perspectives and inside data from the founder of MMD